Skip to main content

Nonprofit · EIN 20-1082179

ALZHEIMERS DRUG DISCOVERY FOUNDATION

Tax-exempt · NEW YORK, NY 10019

Financials

$37.7M$61.9M2023$47.3M$88.3M2024$82.2M$47.6M2025
Revenue Expenses · by fiscal year end
Financials of ALZHEIMERS DRUG DISCOVERY FOUNDATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$82,162,763$47,597,883$34,564,880$315,495,637$63,362,218$252,133,419
December 31, 2024990 (amended)$47,282,987$88,250,427-$40,967,440$299,394,693$82,417,926$216,976,767
December 31, 2023990 (amended)$37,742,020$61,943,588-$24,201,568$324,173,528$64,182,947$259,990,581
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$66,955,109
Program service revenue
$11,651,235
Investment income
$4,154,966
Net gain from sales of assets
-$8,426
Net income from fundraising events
-$598,547
Other revenue
-$598,547

Expenses

Grants and similar amounts paid
$30,837,976
Compensation of officers, directors and key employees
$2,352,392
Other salaries and wages
$5,164,582
Salaries, compensation and benefits (total)
$8,830,102
Professional fundraising fees
$0
Legal fees
$245,363
Occupancy
$350,123
Travel
$607,651
Depreciation
$43,306
Program services (functional)
$39,974,593
Management and general (functional)
$3,034,897
Fundraising (functional)
$4,588,393

Balance sheet and other

Total assets, start of year
$299,394,693
Total assets, end of year
$315,495,637
Total liabilities, end of year
$63,362,218
Net assets, end of year
$252,133,419
Land, buildings and equipment
$112,653
Publicly traded securities
$88,836,708
Net assets without donor restrictions
$92,558,628
Net assets with donor restrictions
$159,574,791
Gross receipts
$84,182,965
Employees
37
Volunteers
32
Year formed
2004
State of legal domicile
DE

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
HOWARD FILLIT MDFOUNDING ED & CSO
Trustee or director, Officer
40$691,744$494,274
MARK ROITHMAYRCEO
Officer
40$682,100$58,069
LAURA NISENBAUMEXEC. DIR., DRUG DEV.
Highest-paid employee
40$496,050$53,715
KAREN HARRISCFO & HEAD OF MISSION-REL. INVESTING
Officer
40$384,929$41,275
JANE MCINTOSHCHIEF EXT. AFFAIRS & PHILANTHROPY OFFICER
Highest-paid employee
40$394,697$27,629
AARON BURSTEINHEAD OF SEARCH & EVAL.
Highest-paid employee
40$359,652$61,170
ELI SHOBINSENIOR DIRECTOR DXA
Highest-paid employee
40$330,179$39,967
PIZZONE KATHRYN DATTY., MISSION-REL. INVEST.
Highest-paid employee
40$218,807$53,924
ADAM HOFFMANGOVERNOR
Trustee or director
1$0$0
ALICE SHUREGOVERNOR
Trustee or director
1$0$0
ANN JACKSONGOVERNOR
Trustee or director
1$0$0
BONNIE ENGLEBARDT LAUTENBERGGOVERNOR
Trustee or director
1$0$0
BONNIE PFEIFER EVANSGOVERNOR
Trustee or director
1$0$0
CAROL BOULANGERGOVERNOR
Trustee or director
1$0$0
DAVID DOLBYGOVERNOR
Trustee or director
1$0$0
26 more people on this return
NameTitleHours / weekCompensation
DAVID R WEINREBGOVERNOR
Trustee or director
1$0
GARY M LAUDERGOVERNOR
Trustee or director
1$0
GAVIN COOKGOVERNOR
Trustee or director
1$0
HENRIK ZETTERBERG MD PHDGOVERNOR
Trustee or director
1$0
JULIEANN SHANAHAN CFAGOVERNOR
Trustee or director
1$0
LANNY EDELSOHN MDGOVERNOR
Trustee or director
1$0
LAURA STEELEGOVERNOR
Trustee or director
1$0
LAURENCE LEEDS JRGOVERNOR
Trustee or director
1$0
LEONARD LAUDERCO-CHAIR/GOVERNOR (DECEASED 06/25)
Trustee or director, Officer
1$0
MIIA KIVIPELTO MD PHDGOVERNOR
Trustee or director
1$0
NANCY CORZINEGOVERNOR
Trustee or director
1$0
NANCY GOODESGOVERNOR
Trustee or director
1$0
NIRANJAN BOSE PHDGOVERNOR
Trustee or director
1$0
PAULA ZAHNGOVERNOR
Trustee or director
1$0
PHILIP SCHELTENS MD PHDGOVERNOR
Trustee or director
1$0
RACHID IZZARGOVERNOR
Trustee or director
1$0
RANDAL SANDLERCO-VICE CHAIR & SECRETARY
Trustee or director, Officer
1$0
RIC EDELMANGOVERNOR
Trustee or director
1$0
RICHARD C MOHSGOVERNOR
Trustee or director
1$0
ROBERT A BELFERGOVERNOR
Trustee or director
1$0
ROBERTA DIAZ BRINTON PHDGOVERNOR
Trustee or director
1$0
RONALD S LAUDERCO-CHAIRMAN /GOVERNOR
Trustee or director, Officer
1$0
SALLY SUSMANGOVERNOR
Trustee or director
1$0
SHARON T SAGERGOVERNOR
Trustee or director
1$0
THOMAS F MCWILLIAMSCO-VICE CHAIRMAN & TREASURER
Trustee or director, Officer
1$0
THOMAS S SMITH JRGOVERNOR
Trustee or director
1$0
990 for the year ended December 31, 2024: 37 people
NameTitleHours / weekCompensationOther / benefits
HOWARD FILLIT MDFOUNDING EXEC. DIR. & CHIEF SCIENCE OFF.
Trustee or director, Officer
40$663,174$477,923
MARK ROITHMAYRCEO
Officer
40$651,120$41,302
LAURA NISENBAUMEXECUTIVE DIRECTOR, DRUG DEVELOPMENT
Highest-paid employee
40$442,772$36,746
KAREN HARRISCFO AND HEAD OF MISSION RELATED INV
Officer
40$369,039$26,221
JANE MCINTOSHCHIEF EXTERNAL AFFAIRS
Highest-paid employee
40$377,792$13,781
AARON BURSTEINHEAD OF SEARCH AND EVALUATION
Highest-paid employee
40$314,231$53,853
ELI SHOBINSENIOR DIRECTOR DXA
Highest-paid employee
40$235,962$34,096
LAKITA CAVINATTORNEY, MISSION-RELATED
Highest-paid employee
40$220,246$20,989
ADAM HOFFMANGOVERNOR
Trustee or director
1$0$0
ALICE SHUREGOVERNOR
Trustee or director
1$0$0
ANN JACKSONGOVERNOR
Trustee or director
1$0$0
BONNIE ENGLEBARDT LAUTENBERGGOVERNOR
Trustee or director
1$0$0
BONNIE PFEIFER EVANSGOVERNOR
Trustee or director
1$0$0
CAROL BOULANGERGOVERNOR
Trustee or director
1$0$0
DAVID WEINREBGOVERNOR
Trustee or director
1$0$0
GARY M LAUDERGOVERNOR
Trustee or director
1$0$0
HENRIK ZETTERBERG MD PHDGOVERNOR
Trustee or director
1$0$0
JULIEANN SHANAHAN CFAGOVERNOR
Trustee or director
1$0$0
LANNY EDELSOHN MDGOVERNOR
Trustee or director
1$0$0
LAURA STEELEGOVERNOR
Trustee or director
1$0$0
LAURENCE LEEDS JRGOVERNOR
Trustee or director
1$0$0
LEONARD LAUDERCO-CHAIRMAN /GOVERNOR (DECEASED)
Trustee or director, Officer
1$0$0
MIIA KIVIPELTO MD PHDGOVERNOR
Trustee or director
1$0$0
NANCY CORZINEGOVERNOR
Trustee or director
1$0$0
NANCY GOODESGOVERNOR
Trustee or director
1$0$0
NIRANJAN BOSE PHDGOVERNOR
Trustee or director
1$0$0
PAULA ZAHNGOVERNOR
Trustee or director
1$0$0
PHILIP SCHELTENS MD PHDGOVERNOR
Trustee or director
1$0$0
RACHID IZZARGOVERNOR
Trustee or director
1$0$0
RANDAL SANDLERCO-VICE CHAIRMAN & SECRETARY
Trustee or director, Officer
1$0$0
RIC EDELMANGOVERNOR
Trustee or director
1$0$0
RICHARD MOHS PHDGOVERNOR
Trustee or director
1$0$0
ROBERTA DIAZ BRINTON PHDGOVERNOR
Trustee or director
1$0$0
RONALD LAUDERCO-CHAIRMAN /GOVERNOR
Trustee or director, Officer
1$0$0
SHARON SAGERGOVERNOR
Trustee or director
1$0$0
THOMAS MCWILLIAMSCO-VICE CHAIRMAN & TREASURER
Trustee or director, Officer
1$0$0
THOMAS SMITH JRGOVERNOR
Trustee or director
1$0$0
990 for the year ended December 31, 2023: 30 people
NameTitleHours / weekCompensationOther / benefits
HOWARD FILLIT MDFOUNDING EXEC. DIR. & CHIEF SCI. OFF.
Trustee or director, Officer
40$632,502$475,582
MARK ROITHMAYRCEO
Officer
40$619,606$39,387
LAURA NISENBAUMEXECUTIVE DIRECTOR, DRUG DEV.
Highest-paid employee
40$434,157$32,393
KAREN HARRISCFO AND HEAD OF MISSION
Officer
40$366,749$24,726
JANE MCINTOSHCHIEF EXTERNAL AFFAIRS
Highest-paid employee
40$359,470$12,350
AARON BURSTEINHEAD OF SEARCH AND EVALUATION
Highest-paid employee
40$301,736$48,360
LAKITA CAVINATTORNEY, MISSION-RELATED INVESTMENTS
Highest-paid employee
40$208,205$21,418
CHRISTOPHER CARLSONDIRECTOR, SEARCH & EVALUATION
Highest-paid employee
40$182,770$30,842
ALICE SHUREGOVERNOR
Trustee or director
1$0$0
BEATRIZ ILLESCAS PUTZEYS-CLAUGUSGOVERNOR
Trustee or director
1$0$0
BONNIE PFEIFER EVANSGOVERNOR
Trustee or director
1$0$0
DAVID WEINREBGOVERNOR
Trustee or director
1$0$0
GARY M LAUDERGOVERNOR
Trustee or director
1$0$0
LANNY EDELSOHN MDGOVERNOR
Trustee or director
1$0$0
LAURENCE LEEDS JRGOVERNOR
Trustee or director
1$0$0
LEONARD LAUDERCO-CHAIRMAN /GOVERNOR
Trustee or director, Officer
1$0$0
MELVIN GOODESHONORARY GOVERNOR
Trustee or director
1$0$0
MIIA KIVIPELTO MD PHDGOVERNOR
Trustee or director
1$0$0
NANCY CORZINEGOVERNOR
Trustee or director
1$0$0
NANCY GOODESGOVERNOR
Trustee or director
1$0$0
PAULA ZAHNGOVERNOR
Trustee or director
1$0$0
RANDAL SANDLERCO-VICE CHAIRMAN & SECRETARY
Trustee or director, Officer
1$0$0
RICHARD MOHS PHDGOVERNOR
Trustee or director
1$0$0
ROBERT BELFERGOVERNOR
Trustee or director
1$0$0
ROBERTA DIAZ BRINTON PHDGOVERNOR
Trustee or director
1$0$0
RONALD LAUDERCO-CHAIRMAN /GOVERNOR
Trustee or director, Officer
1$0$0
SANDRA DAY O'CONNORHONORARY CHAIRMAN
Trustee or director
1$0$0
SHARON SAGERGOVERNOR
Trustee or director
1$0$0
THOMAS MCWILLIAMSCO-VICE CHAIRMAN & TREASUR
Trustee or director, Officer
1$0$0
THOMAS SMITH JRGOVERNOR
Trustee or director
1$0$0

Address and contacts

Address (IRS master file)
57 W 57TH ST STE 904, NEW YORK, NY 10019-2819
In care of
% HOWARD FILLIT MD
Principal officer (990 for 2025)
ISOBEL COLEMAN, 57 WEST 57TH ST 904, NEW YORK, NY 10019
Signed the 990
ISOBEL COLEMAN, CEO
Phone
(212) 901-8000
Return prepared by
CBIZ ADVISORS LLC

Mission

ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS.

990 for the year ended December 31, 2025

Program accomplishments

  • THE ALZHEIMER'S DRUG DISCOVERY FOUNDATION IS DEDICATED TO RAPIDLY ACCELERATING THE DISCOVERY OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS. THE ADDF IS SOLELY FOCUSED ON FUNDING THE DEVELOPMENT OF DRUGS FOR ALZHEIMER'S, EMPLOYING A VENTURE PHILANTHROPY MODEL TO SUPPORT RESEARCH IN ACADEMIA AND THE BIOTECH INDUSTRY.
    Expenses $39,974,593 · grants $30,837,976 · revenue $11,651,235

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
20-1082179
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2005
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Social science (V36)
Assets (IRS master file)
$315,495,637
Income (IRS master file)
$84,182,965

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$82,162,763$47,597,883$315,495,637XML
990December 2024$47,282,987$88,250,427$299,394,693XML
990December 2023$37,742,020$61,943,588$324,173,528XML
990December 2022$254,027,105$36,842,901$340,253,841IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2019–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 20-1082179).

Questions about ALZHEIMERS DRUG DISCOVERY FOUNDATION

What is the EIN of ALZHEIMERS DRUG DISCOVERY FOUNDATION?
The employer identification number (EIN) of ALZHEIMERS DRUG DISCOVERY FOUNDATION is 20-1082179.
Is ALZHEIMERS DRUG DISCOVERY FOUNDATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2005.
Are donations to ALZHEIMERS DRUG DISCOVERY FOUNDATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does ALZHEIMERS DRUG DISCOVERY FOUNDATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of ALZHEIMERS DRUG DISCOVERY FOUNDATION due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did ALZHEIMERS DRUG DISCOVERY FOUNDATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of ALZHEIMERS DRUG DISCOVERY FOUNDATION?
The 990 for the year ended December 31, 2025 names ISOBEL COLEMAN.
Who are the officers and directors of ALZHEIMERS DRUG DISCOVERY FOUNDATION?
The 990 for the year ended December 31, 2025 lists 41 people; 8 received compensation from the organization, the highest $691,744 (HOWARD FILLIT MD, FOUNDING ED & CSO).
How much revenue does ALZHEIMERS DRUG DISCOVERY FOUNDATION have?
On its 990 for the year ended December 31, 2025 it reported revenue of $82,162,763, expenses of $47,597,883 and total assets of $315,495,637 at year end.

Other nonprofits in NEW YORK

All nonprofits in NEW YORK · New York · Social science